Salix Pharmaceuticals - Advancing Treatment in Gastroenterology

Management Team

Our Executive Management Team focuses on the day-to-day operation of Salix Pharmaceuticals.

Carolyn J. Logan

President and Chief Executive Officer

Ms Logan has served as Salix President and Chief Executive Officer and as a member of the Board of Directors since July 2002. She previously served as Senior Vice President, Sales and Marketing, from 2000 to July 2002. Ms Logan has approximately 35 years of specialty pharmaceutical sales and marketing experience, including extensive experience building and/or rebuilding specialty pharmaceutical sales forces. Before joining Salix, she served as Vice President, Sales and Marketing, of the Oclassen Dermatologics division of Watson Pharmaceuticals, Inc, from May 1997 to June 2000, and as Vice President, Sales, from February 1997 to May 1997. Before that date, she served as Director, Sales, of Oclassen Pharmaceuticals, Inc, from January 1993 to February 1997. Before joining Oclassen, Ms Logan held various sales and marketing positions of increasing responsibility with Galderma Laboratories, Ulmer Pharmacal, and Westwood-Squibb Pharmaceuticals, Inc, a subsidiary of Bristol-Myers Squibb. Ms Logan received a BS in Biology and Dental Hygiene from the University of North Carolina at Chapel Hill.

Timothy J. Creech

Senior Vice President, Finance and Administrative Services and Acting Chief Financial Officer

Mr. Creech who joined Salix in March 2007 as Executive Director, Finance, serves as Senior Vice President, Finance and Administrative Services and was appointed Acting Chief Financial Officer in November 2014. Mr. Creech has over 30 years of accounting and financial experience, including approximately 10 years at KPMG LLP and over 20 years in positions of significant responsibility at publicly traded companies. At Salix he previously served as Vice President, Finance and Administrative Services from May 2010 to March 2014, Associate Vice President, Finance from July 2008 to May 2010 and as Executive Director, Finance from March 2007 to July 2008. Prior to joining the Company, Mr. Creech served as Vice President, Finance at Voyager Pharmaceutical Corp. from 2004 to 2007, as Vice President, Finance, Principal Accounting Officer and Secretary at Trimeris, Inc. from 2002 to 2004, as Director of Finance at Trimeris from 1997 to 2002, as Corporate Controller at Performance Awareness Corporation from 1996 to 1997, as Director of Finance and Assistant Secretary at Avant! Corporation (formerly Integrated Silicon Systems) from 1993 to 1996 and at KPMG LLP from 1984 to 1993 in various positions of increasing responsibility progressing to Senior Manager. Mr. Creech received a BS in Business Administration from the University of North Carolina at Chapel Hill and a MBA from the Fuqua School of Business at Duke University.

William P. Forbes, PharmD

Executive Vice President, Medical, Research and Development, and Chief Development Officer

Dr Forbes joined Salix in January 2005 as Vice President, Research and Development, and Chief Development Officer, bringing more than 20 years of experience in pharmaceutical development. Dr Forbes was promoted to Senior Vice President in 2009 and currently is our Executive Vice President, Medical, Research and Development, and Chief Development Officer. Before joining Salix, Dr Forbes served as Vice President, Clinical Development and Regulatory Affairs, at Metabasis Therapeutics, Inc. Before that, he served as a Group Leader at Otsuka America Pharmaceutical, Inc, since 1996, and held various senior management positions in clinical research at Otsuka since 1991. Before joining Otsuka, Dr Forbes served as Senior Clinical Research Scientist at Glaxo, Inc. Dr Forbes has had responsibilities involving the clinical research and development of numerous new chemical entities in a variety of therapeutic indications, including gastroenterology and infectious disease. Dr Forbes received a PharmD from Creighton University and conducted postdoctoral work at the Creighton Cardiac Center and the Cardiovascular Clinical Research Department at Glaxo.

Rick D. Scruggs

Executive Vice President, Business Development

Mr Scruggs joined Salix in 2000 as Director, National Accounts, bringing extensive experience in business development and commercial activities in the pharmaceutical industry. Mr Scruggs was promoted to Senior Vice President in 2009 and to Executive Vice President in 2011. Before joining Salix, Mr Scruggs served as Director of Managed Markets at Watson Pharmaceuticals, Inc, from May 1997 to July 2000. Prior to that, Mr Scruggs served as Director, Managed Markets and Trade, at Oclassen Pharmaceuticals, Inc, from January 1995 to February 1997. Before joining Oclassen, Mr Scruggs held various sales and marketing positions of increasing responsibility with Johnson & Johnson and Ciba-Geigy. Mr Scruggs received a BS in Criminal Justice from Appalachian State University.

Check out our latest Press Releases and News